Liquid chromatography-mass spectrometry based tissue metabolic profiling reveals major metabolic pathway alterations and potential biomarkers of lung cancer

ABSTRACT: MS spectrum of lung tissue metabolic analysis in 131 patients with lung cancer or benign lung tumor. These include lung cancer tissues/benign tumor tissues, adjacent normal tissues and distal normal tissues.

ORGANISM(S): Cancer

SUBMITTER: Guowang Xu  

PROVIDER: PXD019969 | iProX | Fri Jun 19 00:00:00 GMT+01:00 2020

REPOSITORIES: iProX